(Total Views: 94)
Posted On: 09/17/2019 3:30:42 PM
Post# of 145458

$CNCE News Article - Concert Pharmaceuticals Completes Enrollment in Second Open Label Trial of CTP-543 to Evaluate Once-Daily vs. Twice-Daily Dosing in Patients with Alopecia Areata https://marketwirenews.com/news-releases/conc...21878.html


My Twitter: WhyteStocks